GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,082 Cr | ₹1,814 Cr | ₹1,642 Cr | ₹1,173 Cr | ₹893 Cr |
What is the latest Total Current Liabilities ratio of GRANULES INDIA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,082 Cr |
Mar2023 | ₹1,814 Cr |
Mar2022 | ₹1,642 Cr |
Mar2021 | ₹1,173 Cr |
Mar2020 | ₹893 Cr |
How is Total Current Liabilities of GRANULES INDIA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,082 Cr | 14.82 | |
Mar2023 | ₹1,814 Cr | 10.47 | |
Mar2022 | ₹1,642 Cr | 39.94 | |
Mar2021 | ₹1,173 Cr | 31.31 | |
Mar2020 | ₹893 Cr | - |
Compare Total Current Liabilities of peers of GRANULES INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GRANULES INDIA | ₹13,369.0 Cr | -5.5% | -5.7% | 35.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
GRANULES INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GRANULES INDIA | -5.5% |
-5.7% |
35.6% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses